AGNT, Inc., previously known as eXp World holdings, Inc., announced its financial results for the second quarter of 2026. Revenue during the quarter grew 11% to $1.4 billion, compared to $1.3 billion in the same quarter of 2025. Net loss was $2.7 million, or $0.02 per share, with operating expenses of $97.2 million.

Medifast announced its financial results for the second quarter of 2026. Revenue during the quarter was $76.4 million, a 27.6% decrease from Q2 2025, with a net loss of $3.1 million, or $0.28 per diluted share.

USANA Health Sciences, Inc. announced its financial results for the second quarter of 2026. Net sales during the quarter were $223 million, compared to $236 million in Q2 2025. Net loss during the quarter was $21.4 million with an adjusted EBITDA of $27.8 million.

LR Health & Beauty published its final annual report for 2025. Included in the report were preliminary full-year 2025 sales totals, which reached $319 million, down from $333 million in 2024. EBITDA for 2025 is reported at $19 million, compared to $31 million in 2024. Normalized EBITDA for the year was approximately $25.9 million.

Natural Health Trends Corp. announced its financial results for the second quarter of 2026. The company stated that its recently implemented restructuring program has shown positive progress and is reducing costs for the organization and creating savings that is expected to be realized later this year.

Oriflame announced its financial results for the second quarter of 2026. Sales in Latin America saw a 6% boost, while sales in Türkiye and Africa declined 13% and sales in Europe and Asia fell 12% and 11% respectively.